Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12283) 12283
Book Chapter (393) 393
Newspaper Article (230) 230
Dissertation (128) 128
Publication (67) 67
Conference Proceeding (22) 22
Book Review (9) 9
Government Document (9) 9
Magazine Article (9) 9
Book / eBook (8) 8
Trade Publication Article (3) 3
Web Resource (2) 2
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bisphosphonates (8441) 8441
science & technology (7586) 7586
life sciences & biomedicine (7004) 7004
humans (5905) 5905
osteoporosis (4097) 4097
female (3911) 3911
bisphosphonate (3471) 3471
male (2687) 2687
diphosphonates - therapeutic use (2255) 2255
aged (2207) 2207
middle aged (2124) 2124
biological and medical sciences (1844) 1844
animals (1817) 1817
endocrinology & metabolism (1750) 1750
bone density conservation agents - therapeutic use (1733) 1733
medical sciences (1702) 1702
fractures (1602) 1602
diphosphonates - adverse effects (1423) 1423
bones (1360) 1360
orthopedics (1284) 1284
dentistry (1281) 1281
bone density conservation agents - adverse effects (1245) 1245
diphosphonates - administration & dosage (1206) 1206
medicine & public health (1194) 1194
pharmacology. drug treatments (1190) 1190
risk factors (1185) 1185
phosphonates (1151) 1151
zoledronic acid (1115) 1115
oncology (1108) 1108
osteoporosis - drug therapy (1107) 1107
osteonecrosis (1091) 1091
diphosphonates - pharmacology (1070) 1070
dentistry, oral surgery & medicine (979) 979
aged, 80 and over (978) 978
care and treatment (968) 968
diphosphonates (968) 968
adult (936) 936
analysis (932) 932
bone density (930) 930
bone density conservation agents - administration & dosage (929) 929
drug therapy (910) 910
bone mineral density (905) 905
bone density - drug effects (866) 866
treatment outcome (862) 862
rheumatology (860) 860
surgery (860) 860
research (810) 810
denosumab (804) 804
pharmacology & pharmacy (797) 797
alendronate (754) 754
bones, joints and connective tissue. antiinflammatory agents (752) 752
cancer (748) 748
breast cancer (721) 721
patients (713) 713
health aspects (706) 706
diseases of the osteoarticular system (691) 691
bone neoplasms - secondary (684) 684
necrosis (676) 676
endocrinology (658) 658
rats (636) 636
retrospective studies (614) 614
osteoporosis, postmenopausal - drug therapy (611) 611
vitamin d (611) 611
metastasis (600) 600
alendronic acid (582) 582
mice (580) 580
bone resorption (574) 574
bone (561) 561
bone neoplasms - drug therapy (547) 547
bone density conservation agents - pharmacology (534) 534
jaw (521) 521
medicine (521) 521
calcium (489) 489
bone metastases (478) 478
pamidronate (478) 478
general & internal medicine (463) 463
pain (463) 463
tumors (444) 444
multiple myeloma (437) 437
density (432) 432
medicine, general & internal (431) 431
time factors (429) 429
clinical trials (425) 425
physical sciences (425) 425
internal medicine (424) 424
imidazoles - therapeutic use (421) 421
chemistry (415) 415
administration, oral (414) 414
prevention (410) 410
fracture (406) 406
parathyroid hormone (406) 406
abridged index medicus (405) 405
postmenopausal women (396) 396
alendronate - therapeutic use (391) 391
complications and side effects (388) 388
osteoporosis. osteomalacia. paget disease (388) 388
prostate cancer (383) 383
dosage and administration (382) 382
osteonecrosis - chemically induced (381) 381
drugs (379) 379
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12081) 12081
German (310) 310
French (252) 252
Japanese (228) 228
Spanish (178) 178
Portuguese (126) 126
Russian (63) 63
Czech (56) 56
Chinese (46) 46
Polish (46) 46
Korean (41) 41
Italian (22) 22
Hungarian (19) 19
Croatian (7) 7
Turkish (7) 7
Slovenian (6) 6
Norwegian (5) 5
Slovak (4) 4
Persian (3) 3
Belarusian (1) 1
Bosnian (1) 1
Dutch (1) 1
Estonian (1) 1
Hebrew (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
by Khan, Aliya A and Morrison, Archie and Hanley, David A and Felsenberg, Dieter and McCauley, Laurie K and O'Ryan, Felice and Reid, Ian R and Ruggiero, Salvatore L and Taguchi, Akira and Tetradis, Sotirios and Watts, Nelson B and Brandi, Maria Luisa and Peters, Edmund and Guise, Teresa and Eastell, Richard and Cheung, Angela M and Morin, Suzanne N and Masri, Basel and Cooper, Cyrus and Morgan, Sarah L and Obermayer‐Pietsch, Barbara and Langdahl, Bente L and Al Dabagh, Rana and Davison, K. Shawn and Kendler, David L and Sándor, George K and Josse, Robert G and Bhandari, Mohit and El Rabbany, Mohamed and Pierroz, Dominique D and Sulimani, Riad and Saunders, Deborah P and Brown, Jacques P and Compston, Juliet and Int Task Force Osteonecrosis Jaw and International Task Force on Osteonecrosis of the Jaw
Journal of bone and mineral research, ISSN 0884-0431, 01/2015, Volume 30, Issue 1, pp. 3 - 23
OSTEONECROSIS OF THE JAW | DIAGNOSIS | BISPHOSPHONATES | MANAGEMENT | RISK FACTORS | DENOSUMAB | IMAGING | TREATMENT | Treatment | Imaging | Osteonecrosis of the jaw | Diagnosis | Management | Denosumab | Bisphosphonates | Risk factors | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Humans | Osteoporosis - diagnosis | Osteoporosis - drug therapy | Mandible - diagnostic imaging | Monocytes - immunology | Cone-Beam Computed Tomography | Bisphosphonate-Associated Osteonecrosis of the Jaw - immunology | Mandible - immunology | Bacterial Infections - immunology | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging | Osteoporosis - diagnostic imaging | Monocytes - pathology | Diphosphonates - therapeutic use | T-Lymphocytes - pathology | Diphosphonates - adverse effects | Macrophages - immunology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Osteoporosis - immunology | Macrophages - pathology | Risk Factors | Receptors, Antigen, T-Cell, gamma-delta - immunology | Consensus | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnosis | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | T-Lymphocytes - immunology | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Care and treatment | Bacterial infections | Platelet-derived growth factor | Corticosteroids | Diagnostic imaging | Transplantation | T cells | Necrosis | Osteoporosis | Toiletries industry | Stem cells | Bones | Health aspects | Scanning devices | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology
by Fusco, Vittorio and Santini, Daniele and Armento, Grazia and Tonini, Giuseppe and Campisi, Giuseppina
Expert opinion on drug safety, ISSN 1474-0338, 07/2016, Volume 15, Issue 7, pp. 925 - 935
sunitinib | Bisphosphonate | everolimus | temsirolimus | aflibercept | Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) | bevacizumab | Osteonecrosis of the jaw (ONJ) | Medication-Related Osteonecrosis of the Jaw (MRONJ) | denosumab | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Jaw Diseases - diagnosis | Osteonecrosis - diagnosis | Risk Assessment - methods | Humans | Antineoplastic Agents - administration & dosage | Osteonecrosis - pathology | Molecular Targeted Therapy | Neoplasms - drug therapy | Jaw Diseases - chemically induced | Angiogenesis Inhibitors - administration & dosage | Jaw Diseases - pathology | Antineoplastic Agents - adverse effects | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnosis | Quality of Life | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Osteonecrosis - chemically induced | Angiogenesis Inhibitors - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates – preliminary data
by Anon
British dental journal, ISSN 0007-0610, 04/2013, Volume 214, Issue 7, pp. 349 - 349
Bisphosphonates
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Medication‐related osteonecrosis of the jaw after long‐term bisphosphonate treatment in a cat
by Larson, Melinda J and Oakes, Ashley B and Epperson, Ember and Chew, Dennis J
Journal of veterinary internal medicine, ISSN 0891-6640, 03/2019, Volume 33, Issue 2, pp. 862 - 867
hypercalcemia | osteomyelitis | pamidronate | aminobisphosphonate | alendronate | bisphosphonate‐related osteonecrosis of the jaw | bisphosphonate-related osteonecrosis of the jaw | Life Sciences & Biomedicine | Veterinary Sciences | Science & Technology | Cats | Cat Diseases - drug therapy | Oral Ulcer - etiology | Cat Diseases - chemically induced | Bisphosphonate-Associated Osteonecrosis of the Jaw - veterinary | Alendronate - therapeutic use | Alendronate - adverse effects | Animals | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | Diphosphonates - therapeutic use | Female | Hypercalcemia - drug therapy | Hypercalcemia - veterinary | Oral Ulcer - veterinary | Diphosphonates - adverse effects | Bones | Alendronate | Disodium pamidronate | Necrosis | Drugs | Jaw | Edema | Mucosa | Neutrophils | Osteonecrosis | Bisphosphonates | Hypercalcemia | Biomedical materials | Histopathology | Antibiotics | Biopsy | Bone density | SMALL ANIMAL | Case Report
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Role of brain macrophages on IL-1b and fatigue following eccentric exercise-induced muscle damage
by Carmichael, Martin D and Davis, JMark and Murphy, EAngela and Carson, James A and Van Rooijen, N and Mayer, Eugene and Ghaffar, Abdul
Brain, behavior, and immunity, ISSN 0889-1591, 05/2010, Volume 24, Issue 4, pp. 564 - 568
Bisphosphonates
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Issues with the surgical treatment of antiresorptive agent‐related osteonecrosis of the jaws
by Kagami, H and Inoue, M and Kobayashi, A and Taguchi, A and Li, X and Yoshizawa, M
Oral diseases, ISSN 1354-523X, 03/2018, Volume 24, Issue 1-2, pp. 52 - 56
bisphosphonate | osteonecrosis | surgical management | antiresorptives | bisphosphonate‐related osteonecrosis of the jaws | osteonecrosis of the jaws | bisphosphonate-related osteonecrosis of the jaws | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Piezosurgery | Severity of Illness Index | Bone Density Conservation Agents - adverse effects | Humans | Laser Therapy | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | Conservative Treatment | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Denosumab - adverse effects | Diphosphonates - adverse effects | Bisphosphonate-Associated Osteonecrosis of the Jaw - surgery | Bones | Care and treatment | Surgery | Necrosis | Jaw | Clinical aspects | Osteonecrosis | Bisphosphonates | Maxillofacial surgery | Dentistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone
by Lo Faro, Alfredo Fabrizio and Giorgetti, Raffaele and Busardò, Francesco Paolo and Lodi, Giovanni and Martini, Valeria and Pispero, Alberto and Iriti, Marcello and Varoni, Elena Maria
Journal of pharmaceutical and biomedical analysis, ISSN 0731-7085, 01/2019, Volume 162, pp. 286 - 290
Osteonecrosis | Liquid chromatography | Bisphosphonates | Mass spectrometry | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Chemistry, Analytical | Life Sciences & Biomedicine | Science & Technology | Reproducibility of Results | Chromatography, High Pressure Liquid - methods | Bone Density Conservation Agents - adverse effects | Humans | Middle Aged | Male | Zoledronic Acid - metabolism | Tandem Mass Spectrometry | Spectrometry, Mass, Electrospray Ionization | Jaw - metabolism | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnosis | Female | Jaw - drug effects | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Zoledronic Acid - adverse effects | Bisphosphonate-Associated Osteonecrosis of the Jaw - metabolism | Bone Density Conservation Agents - metabolism | Bisphosphonate-Associated Osteonecrosis of the Jaw - surgery | Osteoporosis | Diazo compounds | Usage | Phosphorus compounds | Analysis | Methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
by Endo, Yasuo and Kumamoto, Hiroyuki and Nakamura, Masanori and Sugawara, Shunji and Takano-Yamamoto, Teruko and Sasaki, Keiichi and Takahashi, Tetsu and cDepartment of Oral Anatomy and Developmental Biology and eDivision of Orthodontics and Dentofacial Orthopedics and aDivision of Oral and Maxillofacial Surgery and Showa University and fDivision of Advanced Prosthetic Dentistry and Tohoku University and School of Dentistry and dDivision of Oral Molecular Regulation and Graduate School of Dentistry and bDivision of Oral Pathology
Biological & pharmaceutical bulletin, ISSN 0918-6158, 2017, Volume 40, Issue 6, pp. 739 - 750
clodronate | bisphosphonate | osteonecrosis | inflammation | etidronate | Bisphosphonate | Inflammation | Osteonecrosis | Etidronate | Clodronate | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Analgesics - pharmacology | Analgesics - therapeutic use | Bone Density Conservation Agents - adverse effects | Humans | Bone Resorption - drug therapy | Bone Density Conservation Agents - therapeutic use | Bone Resorption - immunology | Denosumab - adverse effects | Bone Density Conservation Agents - pharmacology | Bisphosphonate-Associated Osteonecrosis of the Jaw - immunology | Animals | Nitrogen - chemistry | Analgesics - chemistry | Diphosphonates - chemistry | Interleukin-1 - immunology | Diphosphonates - therapeutic use | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Denosumab - pharmacology | Diphosphonates - adverse effects | Bisphosphonate-Associated Osteonecrosis of the Jaw - drug therapy | Bisphosphonate-Associated Osteonecrosis of the Jaw - prevention & control | Diphosphonates - pharmacology | Analgesics - adverse effects | Bone Density Conservation Agents - chemistry | Phosphates | Jaw | Transportation | Clinical trials | Cytotoxicity | Infections | Tissues | Bisphosphonates | Bone resorption | Biomedical materials | Pain | Bones | Bacteria | Biocompatibility | Medical research | Cell walls | Nitrogen | Clodronic acid | Soft tissues | Side effects | Etidronic acid | Osteoclasts | Bone (long) | Transporter | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights